Next 10 |
home / stock / hkmpf / hkmpf news
2024-04-12 13:30:00 ET Summary The list ranks stocks based on their market cap and dividend yield alone. What I am looking for is quality dividend stocks with long track records of progressive dividend growth, and while dividend yield is still important, it's a secondary considera...
2024-02-23 10:21:45 ET More on Hikma Pharmaceuticals Hikma Pharmaceuticals PLC (HKMPF) Q4 2023 Earnings Call Transcript Historical earnings data for Hikma Pharmaceuticals Dividend scorecard for Hikma Pharmaceuticals Financial information for Hikma Pharmaceuti...
2024-02-22 12:33:03 ET Hikma Pharmaceuticals PLC (HKMPF) Q4 2023 Earnings Conference Call February 22, 2024, 07:00 AM ET Company Participants Susan Ringdal - EVP, Strategic Planning and Global Affairs Riad Mishlawi - CEO Khalid Nabilsi - CFO Bill Larkins - He...
2024-01-09 03:48:00 ET Summary In terms of dividend yield, there was a clear gap between the portfolio’s yield and the All-Share's yield throughout 2023 and by the end of the year, the portfolio had a dividend yield of exactly 5% compared to the FTSE All-Share’s yield of...
2023-12-01 13:40:47 ET More on Amarin, Amneal, etc. Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Call Transcript Amneal Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation Amarin Corporation plc (AMRN) Q3 2023 Earnings Call Transcript ...
2023-08-08 13:35:40 ET Hikma Pharmaceuticals ( OTCPK:HKMPF ) had declared $0.25/share quarterly dividend Payable Sept. 15; for shareholders of record Aug. 11; ex-div Aug. 9. See HKMPF Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: ...
2023-08-04 12:18:02 ET Hikma Pharmaceuticals PLC (HKMPF) Q2 2023 Earnings Conference Call August 03, 2023 04:30 AM ET Company Participants Susan Ringdal - Executive Vice President, Strategic Planning & Global Affairs Said Darwazah - Chief Executive Officer Ri...
2023-08-04 06:50:57 ET Hikma Pharmaceuticals press release ( OTCPK:HKMPF ): 1H GAAP EPS of $59.30. Revenue of $1.43B (+18.2% Y/Y). For further details see: Hikma Pharmaceuticals GAAP EPS of $59.30, revenue of $1.43B
2023-05-23 06:21:26 ET Shanghai Junshi Biosciences ( OTCPK:SHJBF ) said China's National Medical Products Administration (NMPA) accepted an application seeking expanded approval of toripalimab, in combination with albumin-bound paclitaxel, to treat PD-L1 positive (CPS ≥ 1) untrea...
2023-05-06 05:25:00 ET Summary Hikma Pharmaceuticals is a FTSE 250 generic drug manufacturer that was founded in the Middle East in 1978. The company has many attractive features, including a long track record of progressive dividend growth, so I added it to my dividend portfolio ...
News, Short Squeeze, Breakout and More Instantly...
Hikma Pharmaceuticals Plc Company Name:
HKMPF Stock Symbol:
OTCMKTS Market:
Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals Canada NewsWire LONDON , April 29, 2022 /CNW/ -- Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary ...
Hikma resumes launch of generic Advair Diskus® PR Newswire LONDON , April 20, 2021 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that it has resumed the launch of its generic version of ...
LONDON , Sept. 3, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that the US Court of Appeals for the Federal Circuit today upheld a ruling by the US District Court for the District of Nevada finding that Hikma's gen...